Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
QuantumPharm, Inc. ( (HK:2228) ) just unveiled an announcement.
XtalPi Holdings Limited will seek shareholder approval at its upcoming annual general meeting to adopt a new share scheme aimed at better aligning directors and employees with the company’s long-term interests. The scheme is designed to strengthen incentives for management and staff to support sustained growth, and falls under the share scheme framework set out in Chapter 17 of Hong Kong’s listing rules.
The company also plans to replace its existing constitutional documents with a new memorandum and articles of association to reflect updated regulatory requirements. Key changes include enabling hybrid and virtual shareholder meetings and electronic voting, moves that are expected to enhance corporate governance and shareholder participation once approved by special resolution at the AGM.
More about QuantumPharm, Inc.
XtalPi Holdings Limited is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange under stock code 2228. The company operates in the technology and life sciences space, focusing on leveraging advanced platforms and talent to drive its growth and development in global capital markets.
Average Trading Volume: 56,007,390
Technical Sentiment Signal: Buy
Current Market Cap: HK$43.57B
Learn more about 2228 stock on TipRanks’ Stock Analysis page.

